ZA200806986B - Treatment of duchenne muscular dystrophy - Google Patents

Treatment of duchenne muscular dystrophy

Info

Publication number: ZA200806986B
Authority: ZA; South Africa
Prior art keywords: treatment; muscular dystrophy; duchenne muscular; duchenne; dystrophy
Prior art date: 2006-02-10

Application number

ZA200806986A

Inventor

Graham Michael Wynne

Stephen Paul Wren

Peter David Johnson

Paul Damien Price

Moor Olivier De

Gary Nugent

Richard Storer

Richard Joseph Pye

Colin Richard Dorgan

Original Assignee

Summit Corp Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-10

Filing date

2007-02-09

Publication date

2010-02-24

2007-02-09 Application filed by Summit Corp Plc filed Critical Summit Corp Plc

2010-02-24 Publication of ZA200806986B publication Critical patent/ZA200806986B/en

Links

ZA200806986A 2006-02-10 2007-02-09 Treatment of duchenne muscular dystrophy ZA200806986B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB0602768A GB0602768D0 (en)	2006-02-10	2006-02-10	Treatment of muscular dystrophy

Publications (1)

Publication Number	Publication Date
ZA200806986B true ZA200806986B (en)	2010-02-24

Family

ID=36119905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200806986A ZA200806986B (en)	2006-02-10	2007-02-09	Treatment of duchenne muscular dystrophy

Country Status (3)

Country	Link
CN (1)	CN101420950B (en)
GB (1)	GB0602768D0 (en)
ZA (1)	ZA200806986B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011036130A1 (en) *	2009-09-24	2011-03-31	F. Hoffmann-La Roche Ag	Indole derivatives as crac modulators
AU2013229589A1 (en) *	2012-03-06	2014-09-11	Compound Handling B.V.	Aminomethylene pyrazolones with therapeutic activity
CN107001267A (en) *	2014-08-08	2017-08-01	马合伙人株式会社	Condensed heterocyclic compouds
EP3085785A1 (en) *	2015-04-22	2016-10-26	Université de Strasbourg	Dynamin 2 inhibitor for the treatment of duchenne's muscular dystrophy
WO2017168151A1 (en) *	2016-03-30	2017-10-05	Summit (Oxford) Limited	Composition for the treatment of duchenne muscular dystrophy
AU2019358074A1 (en) *	2018-10-10	2021-05-06	Albert Einstein College Of Medicine	Benzoxazole and related compounds useful as chaperone-mediated autophagy modulators
CN110981827A (en) *	2019-11-29	2020-04-10	浙江工业大学	Synthesis method of 4- (5-nitrobenzo [ d ] oxazole-2-yl) aniline
CN113264894A (en) *	2021-05-24	2021-08-17	陕西维世诺新材料有限公司	Benzoxazole derivative and preparation method thereof
CN113372293A (en) *	2021-06-25	2021-09-10	陕西维世诺新材料有限公司	Preparation method of 2-phenylbenzothiazole derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9815880D0 (en) *	1998-07-21	1998-09-16	Pfizer Ltd	Heterocycles
GB0003256D0 (en) *	2000-02-11	2000-04-05	Darwin Discovery Ltd	Heterocyclic compounds and their therapeutic use
AU2003286757B2 (en) *	2002-11-01	2009-06-04	Merck Sharp & Dohme Corp.	Carbonylamino-benzimidazole derivatives as androgen receptor modulators

2006
- 2006-02-10 GB GB0602768A patent/GB0602768D0/en not_active Ceased
2007
- 2007-02-09 CN CN2007800129468A patent/CN101420950B/en not_active Expired - Fee Related
- 2007-02-09 ZA ZA200806986A patent/ZA200806986B/en unknown

Also Published As

Publication number	Publication date
CN101420950B (en)	2012-04-18
CN101420950A (en)	2009-04-29
GB0602768D0 (en)	2006-03-22

Similar Documents

Publication	Publication Date	Title
IL228598A0 (en)	2013-12-31	Treatment of duchenne muscular dystrophy
IL193314A0 (en)	2009-09-22	Treatment of duchenne muscular dystrophy
GB0715938D0 (en)	2007-09-26	Method of treatment of duchenne muscular dystrophy
PL2170396T3 (en)	2017-07-31	Drug combinations for the treatment of duchenne muscular dystrophy
GB0715087D0 (en)	2007-09-12	Drug combinations for the treatment of duchenne muscular dystrophy
GB0815369D0 (en)	2008-10-01	Compounds for treatment of duchenne muscular dystrophy
GB0821307D0 (en)	2008-12-31	Compounds for treatment of duchenne muscular dystrophy
GB0822981D0 (en)	2009-01-21	Compounds for treatment of duchenne muscular dystrophy
ZA200806630B (en)	2009-06-24	Method of treatment for muscular dystrophy
ZA200806986B (en)	2010-02-24	Treatment of duchenne muscular dystrophy
GB0715939D0 (en)	2007-09-26	Method of treatment of duchenne muscular dystrophy
GB0715937D0 (en)	2007-09-26	Method of treatment og duchenne muscular dystrophy
ZA201000225B (en)	2011-03-30	Treatment of depression
GB0905664D0 (en)	2009-05-13	Compounds for treatment of duchenne muscular dystrophy
GB0723100D0 (en)	2008-01-02	Treatment of HFnEF
GB0602767D0 (en)	2006-03-22	Treatment of muscular dystrophy
GB0905670D0 (en)	2009-05-20	Compounds for treatment of duchenne muscular dystrophy
GB0617740D0 (en)	2006-10-18	Treatment of duchenne muscular dystrophy
GB0619281D0 (en)	2006-11-08	Treatment of duchenne muscular dystrophy
GB0623985D0 (en)	2007-01-10	Treatment of duchenne muscular dystrophy
GB0623984D0 (en)	2007-01-10	Treatment of duchenne muscular dystrophy
GB0617737D0 (en)	2006-10-18	Treatment of duchenne muscular dystrophy
GB0623983D0 (en)	2007-01-10	Treatment of duchenne muscular dystrophy
GB0619283D0 (en)	2006-11-08	Treatment of duchenne muscular dystrophy
GB0619282D0 (en)	2006-11-08	Treatment of duchenne muscular dystrophy